<DOC>
	<DOCNO>NCT00700063</DOCNO>
	<brief_summary>This Phase IIb study design assess safety efficacy 0.005 % , 0.01 % 0.015 % PEP005 Topical Gel apply area skin , contain 4-8 AK lesion face scalp .</brief_summary>
	<brief_title>A Multicenter Study Evaluate Safety Efficacy PEP005 Topical Gel When Used Treat Actinic Keratoses Head ( Face Scalp )</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<criteria>Must male female Female patient must Nonchildbearing potential ; Childbearing potential , provide negative pregnancy test use effective contraception 4 8 AK lesion face scalp Cosmetic therapeutic procedure within 2 week within 2 cm select treatment area . Treatment immunomodulators , interferon/ interferon inducer systemic medication suppress immune system : within 4 week . Treatment 5FU , imiquimod , diclofenac , photodynamic therapy : within 8 week 2 cm treatment area</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Peplin</keyword>
	<keyword>Actinic keratosis</keyword>
	<keyword>PEP005</keyword>
</DOC>